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1. INTRODUCTION {#joa312360-sec-0005}
===============

There is an increasing trend in the number of gender‐affirming surgeries in the United States, with mastectomy being the most frequently performed.[^1^](#joa312360-bib-0001){ref-type="ref"} Typically, patients receive gender‐affirming hormone (GAH) therapy before undergoing the surgical procedure.[^2^](#joa312360-bib-0002){ref-type="ref"} GAH have been shown to be associated with higher incidence of venous thrombosis, myocardial infractions, transient ischemic attacks in transgender patients than the general population.[^3^](#joa312360-bib-0003){ref-type="ref"}, [^4^](#joa312360-bib-0004){ref-type="ref"} This study aims to describe the incidence of arrhythmias in transgender patient who underwent gender‐affirming surgeries in the United States from 2012 to 2015 using the National Inpatient Sample (NIS).

2. METHODS {#joa312360-sec-0006}
==========

This study includes hospitalizations from the NIS which has been described elsewhere.[^5^](#joa312360-bib-0005){ref-type="ref"}, [^6^](#joa312360-bib-0006){ref-type="ref"} We included hospitalizations from January 2012 to September 2015 and identified hospitalizations using International Classifications of Diseases, Ninth Revision, Clinical Modification (ICD‐9‐CM) diagnostic codes. This study included previously utilized ICD‐9‐CM codes to identify study population (N = 18 525).[^7^](#joa312360-bib-0007){ref-type="ref"} We excluded patients below 18 years of age (N = 1970). New‐onset arrhythmias were identified using ICD‐9‐CM diagnosis codes in the secondary columns. This method and ICD‐9‐CM codes have been utilized in the past.[^8^](#joa312360-bib-0008){ref-type="ref"}, [^9^](#joa312360-bib-0009){ref-type="ref"}, [^10^](#joa312360-bib-0010){ref-type="ref"} We used Jonckheere‐Terpstra trend analysis for assessment of the trend in gender‐affirming surgeries from January 2012 to September 2015. The study was considered exempt from the institutional review board review as it utilized already available deidentified hospitalizations data.

3. RESULTS {#joa312360-sec-0007}
==========

We identified 16 555 transgender adult who were hospitalized for gender‐affirming surgeries from 2012 to 2015 and included in the final analysis (Table [1](#joa312360-tbl-0001){ref-type="table"}). The mean age of the population was 39.4 ± 15.3 years. We observed an increasing trend in the number of gender‐affirming surgeries performed during the period (*P* ~trend~ \< .001, Figure [1B](#joa312360-fig-0001){ref-type="fig"}). The incidence of arrhythmia for the entire cohort was 3.68%. Arrhythmia occurred significantly more in those who historically identified as female (*P* = .0029), and those who were significantly older (Table [1](#joa312360-tbl-0001){ref-type="table"}). Fifty‐three percent of the patients historically identified as male. Although black patients represented 21% of the cohort, significantly more arrythmias occurred in this racial group (N = 430, *P* \< .0001). Atrial fibrillation (N = 475, 2.87%) was the most common arrythmia followed by atrial flutter and ventricular tachycardia (Figure [1A](#joa312360-fig-0001){ref-type="fig"}). Both ventricular fibrillation and atrioventricular block occurred with equal frequency and were the least common arrythmias (n = 15 each, 0.09%). The incidence of arrhythmia was highest in patients who had their surgery in hospitals located in the West of the country. The mean length of stay was 6.5 days in those with arrhythmia and was significantly longer than the 5.1 days in those without. Mean cost of hospitalization was about \$11 000 in the no arrythmia group and \$19 000 in the arrythmia group.

###### 

Patient and hospital level characteristic of study population

+----------------------------------------------------------+--------------------+-----------------+-----------+
| Variable name                                            | Without arrhythmia | With arrhythmia | *P*‐value |
|                                                          |                    |                 |           |
|                                                          | N = 15 945 (%)     | N = 610 (%)     |           |
+==========================================================+====================+=================+===========+
| Age (years): mean age ± SD                               | 38.6 ± 14.8        | 59.8 ± 14.1     | \<.001    |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Biological sex[^a^](#joa312360-note-0001){ref-type="fn"} |                    |                 |           |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Female                                                   | 6200               | 295             | .002      |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Male                                                     | 8600               | 315             |           |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Race                                                     |                    |                 |           |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Black                                                    | 2970               | 430             | \<.0001   |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| White                                                    | 9360               | 70              |           |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Other                                                    | 3615               | 110             |           |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Comorbidities                                            |                    |                 |           |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Cigarette smoking                                        | 5335 (33.5)        | 235 (38.5)      | .009      |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Illicit drug use                                         | 3650 (22.9)        | 55 (9)          | \<.001    |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Chronic alcohol use                                      | 1790 (11.2)        | 55 (9)          | .09       |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Chronic lung disease                                     | 3100 (19.4)        | 215 (35.2)      | \<.001    |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Hypertension                                             | 3995 (25)          | 380 (62.3)      | \<.001    |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Diabetes                                                 | 1525 (9.6)         | 155 (25.4)      | \<.001    |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Chronic kidney disease                                   | 620 (3.9)          | 110 (18)        | \<.001    |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Depression                                               | 2315 (14.5)        | 100 (16.4       | .20       |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Chronic liver disease                                    | 800 (5)            | 40 (6.6)        | .09       |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Hospital region                                          |                    |                 |           |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| West                                                     | 5160 (32.4)        | 220 (36.1)      | \<.001    |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Mid‐West                                                 | 3460 (21.7)        | 150 (24.6)      |           |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| North East                                               | 4210 (26.4)        | 125 (20.5)      |           |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| South                                                    | 3115 (19.5)        | 115 (18.9       |           |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Patient outcomes                                         |                    |                 |           |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| All‐cause mortality                                      | 55 (0.4)           | 30 (5)          | \<.001    |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Stroke                                                   | 70 (0.4)           | 30 (5)          | \<.001    |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Length of stay (mean days ± SD)                          | 5.1 ± 7.4          | 6.5 ± 6.4       | \<.001    |
+----------------------------------------------------------+--------------------+-----------------+-----------+
| Cost of hospitalization (mean US\$ ± SD)                 | 11 072 ± 17 687    | 19 302 ± 21 430 | \<.001    |
+----------------------------------------------------------+--------------------+-----------------+-----------+

1145 missing biological sex. SD = standard deviation.
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![Panel A: Number of GAS performed in the United States from January 2012 to September 2015. *P* ~trend~ \< .001. Panel B: Frequency of arrhythmia in transgender patients hospitalized for GAS from January 2012 to September 2015. GAS, gender‐affirming surgeries](JOA3-36-797-g001){#joa312360-fig-0001}

4. DISCUSSION {#joa312360-sec-0008}
=============

This study shows a significant increase in the number of gender‐affirming surgeries and associated arrhythmias. However, frequency of arrhythmia is similar to what we have seen in general population or those underwent noncardiac surgeries of the same age.[^11^](#joa312360-bib-0011){ref-type="ref"} It is unknown if these arrhythmias are because of conditions that pertain to the surgeries themselves, that is, the increased stress response, and if preexisting conditions make patients susceptible to specific arrhythmias.[^12^](#joa312360-bib-0012){ref-type="ref"} The most common arrhythmia in our population, atrial fibrillation (2.87%) is lower than the reported 4% incidence in the general surgery population.[^11^](#joa312360-bib-0011){ref-type="ref"} The finding that atrial fibrillation as the commonest arrythmia in our cohort, compares well with prior analyses using the NIS for various disease states.[^5^](#joa312360-bib-0005){ref-type="ref"}, [^8^](#joa312360-bib-0008){ref-type="ref"}, [^9^](#joa312360-bib-0009){ref-type="ref"}, [^13^](#joa312360-bib-0013){ref-type="ref"} It has been hypothesized that low testosterone in transgender females may increase the risk for atrial and ventricular arrhythmia.[^14^](#joa312360-bib-0014){ref-type="ref"} There is higher incidence of atrial fibrillation in postmenopausal women on estrogen replacement therapy. Taken together, these studies support a likely influence of GAH, which transgender patients generally take prior to undergoing GAS, on incidence of perioperative arrhythmias. Incident arrythmias may require increased surveillance, involvement of subspecialists and likely admission to intensive care units, which can affect length of hospital stay, cost of hospitalization, and in‐hospital mortality. Patients in the West region experienced significantly more arrythmia. We speculate that since three of the top five states with the most adults identifying as transgender are in West region (ie, Hawaii, California, and New Mexico) those patients are more likely to have undergone GAS and included in the study.[^15^](#joa312360-bib-0015){ref-type="ref"} Arrhythmia was also associated with over \$8000 more in cost of hospitalization and this is significant. There was an excess 4.6% all‐cause mortality in those who experienced an arrythmia (NNH = 22).

Limitations of this study stem from our use of the NIS database. Limitations inherent in this database include but not limited to inability to validate the diagnoses, lack of information on the specific cause of death, inability to distinguish if patients were male‐to‐female or female‐to‐male transgender, and medication use. We are unable to determine whether the arrhythmias were associated with the surgical procedures themselves or patients were more susceptible to arrhythmia because of the gender‐affirming hormones they may have taken. We do not have information of QT interval duration, which is significantly affected by hormone use and psychotropic medications. Finally, these arrhythmias may occur outside of the hospital which were not captured since our analysis is limited to the in‐patient setting only.

5. CONCLUSION {#joa312360-sec-0009}
=============

The overall prevalence of arrhythmias is similar to general population and risk does not seem to be elevated in this population undergoing gender‐affirming surgery in the inpatient setting. The most common arrythmia in this patient population was atrial fibrillation. New‐onset arrhythmias while rare, present significantly excess all‐cause mortality, longer length of hospitalization, and higher cost of care in transgender patients who had gender‐affirming surgeries.
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